This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend CPC

CPC 2022 Programme

Subpage Hero

.

Loading

Treatment of cancer associated thrombosis

13 May 2022
Clinical Leadership
Treatment of cancer associated thrombosis

 

 

 

 

This session offers pharmacists the opportunity to gain an insight into the management of cancer associated thrombosis (CAT), including recent developments in anticoagulant treatment options, developments in the prevention of CAT, and examples of pharmacist-led CAT pathways

Learning outcomes:

- To understand the prevalence, aetiology and pathophysiology of cancer associated thrombosis (CAT)
- To gain an insight into the treatment and prevention strategies for CAT
- To gain an awareness of pharmacy-led CAT pathways

 

 

Speakers
Kieron Power, Clinical Lead Pharmacist for Thrombosis and Anticoagulation - Swansea Bay University Health Board

Partners

Lead Education Partner

  • CPPE
  • Morph

 

Education Partner

  • APTUK
  • BOPA
  • BPNG
  • CMHP
  • Health Education England

 

Education Partner

  • HIVPA
  • UKRPG
  • NHS England and NHS Improvement
  • NHS Digital
  • NHSx
  • PTOC
  • GPHC

 

Education Partner

  • NPPG
  • PCPA
  • PDA
  • Pharmacist Support
  • RPUK
  • SPS

 

Education Partner

  • Soar Beyond
  • NHCA
  • UKBPA
  • UKCPA
  • PrescQIPP
  • Pharmacy Declares
  • GHP and RPS

 

Media Partner

  • C&D
  • PDA
  • PrescQIPP
  • Scottish Healthcare Review
  • Welsh Healthcare Review
  • NI Healthcare Review
  • Prescriber

 

Nominated Charity

  • Pharmacist Support

 

Newsletter Sign Up